EW vs RELY · P/E 47, rev $1.39B vs rev $1.26B
Edwards Lifesciences Corp (EW) versus Remitly Global Inc (RELY) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Remitly Global Inc (RELY) is a software - infrastructure company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RELY revenue for 2024-12-31 was $1.26B. Net income was -$37.0M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. RELY currently screens at market cap $3.77B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RELY currently screens at market cap $3.77B.
Not investment advice. Open the EW and RELY stock pages for the full models.
Not investment advice.